An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: Evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS

Neuroendocrinology Letters

Volumn 29, Issue 3, 2008, Pages 313-319

  Maes, Michael ^a   Mihaylova, Ivana ^a   Kubera, Marta ^b   Leunis, Jean Claude ^c  

^a MCare4U Outpatient Clinics   (Belgium)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c Laboratory Ategis   (Belgium)

Author keywords

Chronic fatigue syndrome; Cytokines; Depression; IgM; Inflammation; Leaky gut; Nitrosative stress; Oxidative stress; Serum bovine albumin

Indexed keywords

ANTIOXIDANT; BACTERIUM LIPOPOLYSACCHARIDE; BOVINE SERUM ALBUMIN; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTEROBACTERIACEAE; EPITHELIUM; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE MUCOSA PERMEABILITY; MAJOR DEPRESSION; MUSCLE TONE; NITROSATIVE STRESS; OXIDATIVE STRESS; PAIN; PREVALENCE;

EID: 48049089358     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Maes M: From Freud to Omega-3. 2005, Brussels, Standaard Uitgeverij.
2. Maes M, Schotte C, Maes L, Cosyns P: Clinical subtypes of unipolar depression: Part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups. PsychiatrRes 1990; 34(I): 43-57.
3. National Institute of Allergy and Infectious Diseases, National Institute for Health: Chronic Fatigue Syndrome: Information for physicians. NIH publication 1996; No 96-484.
4. Maes M, Mihaylova I, Leunis J-C: Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 2007; 28(6): 861-7.
5. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ: Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biol Med 2005; 39(5): 584-589.
6. Smirnova IV, Pall ML: Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol Cell Biochemistry 2003; 248(1-2): 93-95.
7. Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, De Laurentis S, Affaitati G, De Cesare D, Giamberardino MA: Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosc Lett 2003; 335(3): 151-154.
8. Maes M, Mihaylova I, Leunis JC: Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett 2006; 27(5): 615-621.
9. Maes M, Mihaylova I, Bosmans E: Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuro Endocrinol Lett 2007; 28(4): 456-462.
10. Maes M, Mihaylova I, Kubera M, Bosmans E: Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro Endocrinol Lett 2007; 28(4): 463-469.
11. Mihaylova I, DeRuyter M, Rummens JL, Bosmans E, Maes M: Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett 2007; 28(4): 477-483.
12. Gerrity TR, Papanicolaou DA, Amsterdam JD, Bingham S, Grossman A, Hedrick T, Herberman RB, Krueger G, Levine S, Mohagheghpour N, Moore RC, Oleske J, Snell CR: CFIDS Association of America. Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. Neuroimmunomodulation 2004; 11: 351-357.
13. Maes M, Mihaylova I, De Ruyter M: Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord 2006; 90(2-3): 141-147.
14. Maes M, Mihaylova I, De Ruyter M: Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in Chronic Fatigue Syndrome (CFS): Relevance for the inflammatory response in CFS. Neuro Endocrinol Lett 2005; 26(5): 487-492.
15. Maes M, Mihaylova I, Leunis JC: In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuro Endocrinol Lett 2005; 26(6): 745-751.
16. Singh A, Naidu PS, Gupta S, Kulkarni SK: Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 2002; 5(4): 211-220.
17. Singh A, Garg V, Gupta S, Kulkarni SK: Role of antioxidants in chronic fatigue syndrome in mice. Indian J Exp Biol 2002; 40(11): 1240-1244.
18. Singal A, Kaur S, Tirkey N, Chopra K: Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice. J Med Food 2005; 8(I): 47-52.
19. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R: Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Report 2003; 8(6): 365-370.
20. Lukash AI, Zaika VG, Kucherenko AO, Miliutina NP: Free radical processes and antioxidant system in depression and treatment efficiency. Zhurnal Nevrologii 1 Psikhiatrii Imeni S S Korsakova 2002; 102(9): 41-44.
21. Irie M, Miyata M, Kasai H: Depression and possible cancer risk due to oxidative DNA damage. J Psychiatr Res 2005; 39(6): 553-560.
22. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S: Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007; 22(2): 67-73.
23. Forlenza MJ, Miller GE: Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosom Med 2006; 68(I): 1-7.
24. Maes M, De Vos N, Demedts P, Wauters A, Neels H: Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord 1999; 56(2-3): 189-194.
25. Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, Christophe A: Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 2000; 58(3): 241-246.
26. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O: Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004; 19(2): 89-95.
27. Pal SN, Dandiya PC: Glutathione as a cerebral substrate in depressive behavior. Pharmacol BiochemBeh 1994; 48(4): 845-851.
28. Shaw PX: Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Arch Immunol Ther Exp (Warsz) 2004; 52(4): 225-239.
29. Ohmori H, Kanayama N: Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev 2005; 4(4): 224-229.
30. Bodet D, Glaize G, Dabadie MP, Geffard M: Immunological follow-up for multiple slerosis. Immuno-Analyse & Biologie Specialisee 2004; 19: 138-147.
31. Han GD, Matsuno M, Ito G, Ikeucht Y, Suzuki A: Meat allergy: investigation of potential allergenic proteins in beef. Biosci Biotechnol Biochem 2000; 64(9): 1887-1895.
32. Szepfalusi Z, Ebner C, Urbanek R, Ebner H, Schemer O, Boltz-Nitulescu G, Kraft D: Detection of IgE antibodies specific for allergens in cow milk and cow dander. Int Arch Allergy Immunol 1993; 102(3): 288-294.
33. Restani P, Fiocchi A, Beretta B, Velona T, Giovannini M, Galli CL: Meat allergy: III - Proteins involved and cross-reactivity between different animal species. J Am Coll Nutr 1997; 16(4): 383-389.
34. Fiocchi A, Restani P, Riva E: Beef allergy in children. Nutrition 2000; 16(6): 454-457.
35. Werfel S, Cooke SK, Sampson HA: Clinical reactivity to beef in children allergic to cow's milk. J Allergy Clin Immunol 1997; 99(3): 293-300.
36. Kanny G, de Hauteclocque C, Moneret-Vautrin DA: Food anaphylaxis to bovine serum albumin. J Allergy Clin Immunol 1998; 101(1 Pt 1): 137-139.
37. Joliat TL, Weber RW: Occupational asthma and rhinoconjunctivitis from inhalation of crystalline bovine serum albumin powder. Ann Allergy 1991; 66(4): 301-304.
38. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A: The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121(12): 953-959.
39. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). American Psychiatric Association, Washington, D.C., 2000.
40. Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG: A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res 2002; 52(6): 501-509.
41. Maes M, Coucke F, Leunis JC: Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro Endocrinol Lett 2007; 28(6): 739-44.
42. Maes M, Mihaylova I, Leunis JC: Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord 2007; 99: 237-240.
43. Matuszczak Y, Farid M, Jones J, Lansdowne S, Smith MA, Taylor AA, Reid MB: Effects of N-acetylcysteine on glutathione oxidation and fatigue during handgrip exercise. Muscle Nerve 2005; 32(5): 633-638.
44. Jammes Y, Steinberg JG, Mambrini O, Bregeon F, Delliaux S: Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med 2005; 257(3): 299-310.
45. Ohmori H, Kanayama N: Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev 2005; 4(4): 224-229.
46. Radi R: Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004; 101(12): 4003-4008.
47. ter Steege JC, Koster-Kamphuis L, van Straaten EA, Forget PP, Buurman WA: Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med 1998; 25(8): 953-963.
48. Kondo N, Agata H, Fukutomi O, Motoyoshi F, Orii T: Lymphocyte responses to food antigens in patients with atopic dermatitis who are sensitive to foods. J Allergy Clin Immunol 1990; 86(2): 253-260.
49. Lefvert AK: Recurrent angioedema caused by circulating immune complexes containing antibodies against bovine proteins. Int Arch Allergy Immunol 1993; 102(1): 112-116.
50. Wuthrich B, Stern A, Johansson SG: Severe anaphylactic reaction to bovine serum albumin at the first attempt of artificial insemination. Allergy 1995; 50(2): 179-183.
51. Morales C, Braso JV, Pellicer A, Ruiz A, Pelaez A: Serum sickness due to bovine serum albumin sensitization during in vitro fertilization. J Invest Allergol Clin Immunol 1994; 4(5): 246-249.
52. Haroun M: Bovine serum albumin antibodies as a disease marker for hepatitis e virus infection. J Biomed Biotechnol 2005; 2005(4): 316-321.
53. Atkinson MA, Bowman MA, Kao KJ, Campbell L, Dush PJ, Shah SC, Simell O, Maclaren NK: Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med. 1993; 329(25): 1853-1858.
54. Gerstein HC: Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature. Diabetes Care 1994; 17(1): 13-19.
55. Rodriguez-Juan C, Sala-Silveira L, Perez-Bias M, Valeri AP, Aguilera N, Lopez-Santalla M, Fuertes A, Martin-Villa JM: Increased levels of bovine serum albumin antibodies in patients with type 1 diabetes and celiac disease-related antibodies. J Pediatr Gastroenterol Nutr 2003; 37(2): 132-135.
56. Maes M, Kubera M, Leunis J-C: The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008; 29(1): 117-24.
57. Wu GH, Wang H, Zhang YW, Wu ZH, Wu ZG: Glutamine supplemented parenteral nutrition prevents intestinal ischemia-reperfusion injury in rats. World J Gastroenterol 2004; 10(17): 2592-2594.
58. Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E: The immune effects of TRYCATs (tryptophan catabolites along the ido pathway): Relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol Lett. 2007; 28(6): 826-31.
59. Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S: Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol Med 2001; 31(5): 847-858.
60. Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M: Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 2002; 22(I): 86-90.